“

Tremendous opportunity lies in improving health outcomes by incorporating patient perspectives, needs, and lived experiences throughout the drug development process.

Aneth leads engagements for our life sciences clients, bringing transformative insights and strategies that drive health and business outcomes. She’s a biomedical scientist and strategist trained in biochemistry and molecular pharmacology. Aneth specializes in leading complex, multidisciplinary projects where primary market research and data analytics generate strategic insights. Her work is driven by delivering human-centric health solutions and improving people’s health outcomes.

Experience and achievements

Extensive experience in pharmaceutical research and development
Led due diligence and developed commercial strategies for development programs across a breadth of therapeutic areas, including neurology, psychiatry, oncology, ophthalmology, rare diseases and metabolic disorders
Previously Associate Director of New Product Planning at Sumitomo Pharma America
Holds a PhD in Biochemistry and Molecular Pharmacology from UMass Chan Medical School and is pursuing an MBA from the Isenberg School of Management at UMass Amherst, expected to be completed May 2024